Pharmacy benefit management

The plan to eventually phase out rebates portends a seismic shift in the flow of billions of dollars among drugmakers, insurers and employers.

Key to cost containment lies in partnering with transparent PBMs, a more thoughtful approach to prescribing GLP-1s and encouraging the uptake of biosimilars.

Without the right contractual terms in place, hidden costs may mar pooled purchasing power at the expense of employer clients.

Rice University's executive director of HR operations ditched a traditional model for one that's providing lower costs and better customer service.

Amid high-profile, class-action lawsuits over inflated prescription drug prices, advisers are urged to cement a fiduciary process for employer clients.

Definitive steps can be taken to strategically optimize pharmacy benefits in a way that balances cost with quality care.

Examine adaptability and foresight to understand the intricacies of an evolving pharmaceutical market.

Bipartisan support is building to make pharmacy benefit managers more transparent and accountable, which would benefit millions of working Americans.

The insurance giant's pharmacy-benefit management unit will market a "fully transparent" option charging a flat monthly fee for each member.